The change in m6A modification and the transcript level of four glioma reprogramming factors (SOX2, SALL2, OLIG2 and POU3F2) and selected transcripts were validated by m6A RIP-PCR and RT-qPCR (Figure 2H,I). This evidence concerns the gene SALL2 and central nervous system cancer.